Jump Financial’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Jump Financial's IRMD Position: Q1 2026 in Review
Jump Financial reduced its iRadimed (IRMD) stake by 31% in Q1 2026, selling an estimated $569K and leaving 12,631 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #846.
Jump Financial first reported a position in IRMD in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.78M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Jump Financial held 12,631 shares of iRadimed worth $1.22M as of Q1 2026.
- Jump Financial sold 5,686 iRadimed shares in Q1 2026, an estimated $569K.
- iRadimed made up 0.02% of Jump Financial's portfolio in Q1 2026, its #846 holding.
- Jump Financial first reported a position in iRadimed in Q4 2021 and has held it in 14 quarters since.
- Jump Financial's iRadimed position peaked at $1.78M in Q4 2025.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.